Clinical trial
Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)
NCT03460730 is registered in ClinicalTrials.gov with KEMRI-Wellcome Trust Collaborative Research Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)
- Lead sponsor
- KEMRI-Wellcome Trust Collaborative Research Program
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 4, 2004
- Completion date
- July 3, 2006
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.